🇺🇸 FDA
Patent

US 8217066

Compounds as lysophosphatidic acid receptor antagonists

granted A61KA61K31/42A61K31/422

Quick answer

US patent 8217066 (Compounds as lysophosphatidic acid receptor antagonists) held by AMIRA PHARMACEUTICALS, INC. expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/42, A61K31/422, A61K31/427, A61K31/4439